Advent International is set to invest $175 million in Felix Pharmaceuticals, acquiring a significant minority stake. Felix Pharma, a Dublin...

Piramal Pharma on Tuesday reported net profit of Rs 4 crore in Q3FY25.

Piramal Pharma reported a significant increase in consolidated net profit for Q2, growing from Rs 5 crore last year to Rs 23 crore. Revenue...

For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership i...

The acquisition will enable BAL to leverage SFCL's proficiency in developing cost-effective and distinctive manufacturing routes for off-pa...

Companies in the sectors including pharmaceutical, information technology, automobile and even conventional manufacturing companies are app...

PI Industries Ltd., incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 44289.55 Crore) operating in Pesticide...

Aurobindo Pharma has inked an agreement through its subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica.

The total income of the company increased by 5 per cent to Rs 837.6 crore during the reported quarter from Rs 797.3 crore in the same perio...

Sitharaman said that India is working on a case based on the fact that several states in the US are also possibly giving a domestic content...

"We believe that top players of the sector will continue to grow strongly in 2013, primarily led by exports.

Apple's landmark victory over Samsung in the patent infringement case affirms the company's claim that some of the key Android features vio...

If you look at the demand environment both locally and internationally, it continues to be reasonably robust.

JPMorgan has upgraded the ratings of Dr Reddy’s Laboratories to ‘Overweight’ from ‘Neutral’, on the back of robust outlook.

Director S N Rai said Lava is looking for expansion of business in Africa and looking at new geographies namely Peru and Chile.

Ramesh Subramanian of Merck & Co, Inc says the firm's growth in India will be steered by new business models.

Wockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.